FDA Guidance Document Development Process 

By Alvin J. Lorman, AAHP Counsel The Food and Drug Administration (FDA) is seeking public comment on a draft “Report and Plan on Best Practices for Guidance.” Guidance documents, rather…

Read More

Increased FDA Scrutiny of Eye Care Category 

By Alvin J. Lorman, AAHP Counsel  The Food and Drug Administration (FDA) last week continued its heightened surveillance on ophthalmic drug products sold without FDA approval or without complying with…

Read More

The HPCUS Friends of the Pharmacopoeia Program

By Dr. William Shevin, President, HPCUS  Due to challenges in general for homeopathy and specifically for the Homeopathic Pharmacopoeia Convention of the United States (HPCUS), the standards-setting organization is launching…

Read More

What’s new at FDA?

The United States Food and Drug Administration is a large organization that changes daily. From the perspective of homeopathic companies, a few important things stand out. FDA published the final…

Read More